Article Details

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $81.82 ...

Retrieved on: 2020-12-14 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $81.82 .... View article details on hiswai:

Excerpt

<b>Vanguard Group</b> Inc. now owns 3,336,975 shares of the biopharmaceutical company's stock worth $84,760,000 after purchasing an additional 385,118 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo